The 2025 program built on its evolving reputation as a multispecialty educational forum that successfully integrates ophthalmology and optometry, premium CME content, and a family-friendly format to ...

Discussions from the EnVision Summit 2025 highlighted several clinical and surgical challenges that are expected to shape ...

China’s National Medical Products Administration (NMPA) has granted regulatory approval for 2 next-generation ophthalmic ...

Andrew G. Lee, MD, and Drew Carey, MD, discuss how optic disc cupping after optic neuritis reflects nerve and ganglion cell ...

Edinburgh Biosciences has reported encouraging early outcomes from a structured long-term safety and performance follow-up ...

Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

This finding was based on the results of a study published in BMJ Open Ophthalmology1 that patients with diabetes who were ...

Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...

The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...

Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex ...

The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...